CardioMEMS, Inc. is a health care and pharmaceutical startup, established in 2001, headquartered in the United States. The company specializes in proprietary wireless sensing and communication technology for the human body, with a focus on improving the management of severe chronic cardiovascular diseases such as heart failure and aneurysms.
The $60.00 million Private Equity Round investment received on 16 September 2010, from St. Jude Medical, has bolstered the advancement of their innovative technology. CardioMEMS' miniature wireless sensors, designed for minimally invasive implantation, transmit critical cardiac output, blood pressure, and heart rate data to aid in patient management.
Boasting small size, durability, and lacking wires and batteries, these sensors are engineered for permanent implantation into the cardiovascular system, transmitting real-time data via radiofrequency energy to an external electronics module, successfully communicating with the patient’s physician.
We care about your data, and we'd love to use cookies make your experience better.